Skip to content
Advertisement

Scott Berkheiser, 57, who has Alzheimer's disease, sits for a portrait at his home Friday, April 5, 2024, in Venice, Fla. Insurance denials delayed Berkheiser’s first Leqembi infusion a few months until last December. He said the drugmaker eventually agreed to give it to him for free while he makes co-payments for the infusions. “It was a little crazy,” he said. “It seemed like it was kind of a game that must make sense for some monetary reason.” (AP Photo/Chris O'Meara)

Scott Berkheiser, 57, who has Alzheimer's disease, sits for a portrait at his home Friday, April 5, 2024, in Venice, Fla. Insurance denials delayed Berkheiser’s first Leqembi infusion a few months until last December. He said the drugmaker eventually agreed to give it to him for free while he makes co-payments for the infusions. “It was a little crazy,” he said. “It seemed like it was kind of a game that must make sense for some monetary reason.” (AP Photo/Chris O'Meara)

Featured Photo Galleries